Michael Wong MD, PhD

Michael Wong, MD, Ph.D. is the Allen and Josephine Green Professor of Pediatric Neurology at Washington University School of Medicine. He is a board-certified pediatric epileptologist and clinical neurophysiologist. He is also director of the Washington University Tuberous Sclerosis Center, which provides multidisciplinary care for children and adults with Tuberous Sclerosis Complex and conducts both basic science and clinical research in TSC.

His laboratory investigates mechanisms of epileptogenesis and seizure-induced brain injury in epilepsy. His lab helped established the role of the mechanistic target of rapamycin (mTOR) pathway in epileptogenesis in TSC, as well as in animal models of acquired epilepsy due to brain injury. He has served as a site principal investigator for a number of clinical trials, such as the EXIST-3 trial of the mTOR inhibitor everolimus for epilepsy in TSC and the PREVeNT trial for preventing neurological manifestations of TSC.

He is a past recipient of the American Academy of Neurology Dreifuss-Penry Epilepsy Research Award and is currently an Associate Editor of Epilepsia Open and Senior Editor of Epilepsy Currents. His lab has been funded continuously by NIH and other sources for 20 years and has published over 100 research papers and reviews on epilepsy and TSC.